Cancer Sciences in Glasgow Contribute More Than £500 Million in a Year to UK Economy

That the Parliament welcomes a new report by London Economics, which reveals that cancer research in Glasgow was worth more than half a billion pounds (£503 million) to the UK economy in 2021-22; understands that this economic impact is a direct result of what it considers to be the unique and integrated life sciences ecosystem that has been created in Glasgow and the west of Scotland, led by the University of Glasgow working in collaboration with the NHS, industry, patient groups, government and funders; acknowledges that, of the estimated £503 million of economic impact that cancer sciences in Glasgow generated, £407 million, or 81%, was associated with the impact of the institutions’ combined research activities, while £77 million, or 15%, came from operating and capital spending, and £19 million, or 4%, was attributable to the economic contribution of the institutions’ teaching and learning activities; celebrates that, for every £1 million of research income received, the combined power of research activities of the two institutions reportedly generated a total of £10.2 million in economic impact across the UK; understands that Scotland experiences higher rates of cancer incidence and mortality than the rest of the UK, with disease burden particularly high in Glasgow and the Greater Glasgow area, at more than 700 cases per 100,000 residents; further understands that Glasgow is also home to the largest cancer centre in Scotland, the Beatson West of Scotland Cancer Centre, which sees more than 8,500 new patients and over 60,000 return patients every year; commends the creation of a unique eco-system approach to cancer research in Glasgow and the west, where university researchers work in close partnership with NHS Greater Glasgow and Clyde (NHSGGC), industry, funders and patient groups on world-leading clinical trials and healthcare innovation, and thanks the University of Glasgow School of Cancer Sciences and the Cancer Research UK (CRUK) Beatson Institute for what it sees as their world-leading academic and clinical expertise.